Kathryn (Katy) Cappell, M.D., Ph.D.
- Center for Cancer Research
- National Cancer Institute
- 10 Center Dr
- Bethesda, MD 20892
- 240-234-9341
- kathryn.cappell@nih.gov
RESEARCH SUMMARY
Dr. Cappell’s research focuses on cellular therapies to treat cancers of the blood including non-Hodgkin lymphoma, chronic lymphocytic leukemia, acute lymphoblastic leukemia, myeloid malignancies, and multiple myeloma. Her research efforts are in the development of phase 1 clinical trials. She is also interested in long-term outcomes following CAR T cell therapy.
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
Kathryn (Katy) Cappell, M.D., Ph.D.
Research
Dr. Cappell conducts phase 1 clinical trials of cellular therapies for the treatment of hematologic malignancies.
Biography
Kathryn (Katy) Cappell, M.D., Ph.D.
Dr. Cappell received her Bachelor of Science from the University of Miami. She then completed a joint MD/PhD through the Medical Scientist Training Program (MSTP) at the University of North Carolina at Chapel Hill. Her PhD was in pharmacology and her research focused on identifying modulators of chemosensitivity to paclitaxel. She completed her residency in internal medicine at Stanford University. She also completed a fellowship in Blood and Marrow Transplantation at Stanford. She then completed fellowship training in medical oncology and hematology through the National Cancer Institute. After fellowship, she briefly was in clinical practice before returning to the NCI to join the group of Dr. James Kochenderfer.
Dr. Cappell is board-certified in internal medicine, hematology and medical oncology.